New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers create new tool for assessing risk of kidney injury after chemotherapy

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for
Oncology March 30,2024
Researchers create new tool for assessing risk of kidney injury after chemotherapy

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for
Oncology March 30,2024
Assessing breast cancer risk

Assessing breast cancer risk

by Mayo ClinicCredit: Unsplash/CC0 Public DomainThe genetic risk of breast cancer has been in the news lately. Researchers at the Mayo Clinic Comprehensive Cancer Center are working toward pinpoi
Oncology March 30,2024
Assessing breast cancer risk

Assessing breast cancer risk

by Mayo ClinicCredit: Unsplash/CC0 Public DomainThe genetic risk of breast cancer has been in the news lately. Researchers at the Mayo Clinic Comprehensive Cancer Center are working toward pinpoi
Oncology March 30,2024
Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G
Oncology March 30,2024
Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G
Oncology March 30,2024
Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op
Oncology March 30,2024
Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op
Oncology March 30,2024
AI-driven attention mechanisms aid in streamlining cancer pathology reporting

AI-driven attention mechanisms aid in streamlining cancer pathology reporting

by Mark Alewine,Oak Ridge National LaboratoryCredit: Pixabay/CC0 Public DomainArtificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.In partn
Oncology March 30,2024
AI-driven attention mechanisms aid in streamlining cancer pathology reporting

AI-driven attention mechanisms aid in streamlining cancer pathology reporting

by Mark Alewine,Oak Ridge National LaboratoryCredit: Pixabay/CC0 Public DomainArtificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.In partn
Oncology March 30,2024
Heading off financial harms in cancer patients

Heading off financial harms in cancer patients

by Columbia UniversityCredit: Pixabay/CC0 Public DomainA screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.Mos
Oncology March 30,2024
Heading off financial harms in cancer patients

Heading off financial harms in cancer patients

by Columbia UniversityCredit: Pixabay/CC0 Public DomainA screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.Mos
Oncology March 30,2024
Antibody eradicates leukemia stem cells

Antibody eradicates leukemia stem cells

by Sarah C.p. Williams,University of California, Los AngelesBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaThe introduction of the drug imat
Oncology March 30,2024
Antibody eradicates leukemia stem cells

Antibody eradicates leukemia stem cells

by Sarah C.p. Williams,University of California, Los AngelesBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaThe introduction of the drug imat
Oncology March 30,2024
AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA team of international researchers has developed an artificial intelligence (AI) tool that can predict wh
Oncology March 30,2024
AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA team of international researchers has developed an artificial intelligence (AI) tool that can predict wh
Oncology March 30,2024
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

by Will Cushman,University of Wisconsin-MadisonA confocal microscope image of lymphoma cells. It shows mitochondrial localization (red) around cell nuclei (blue). Credit: Lixin Rui, University o
Oncology March 30,2024
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

by Will Cushman,University of Wisconsin-MadisonA confocal microscope image of lymphoma cells. It shows mitochondrial localization (red) around cell nuclei (blue). Credit: Lixin Rui, University o
Oncology March 30,2024
Antibiotics can inhibit skin lymphoma

Antibiotics can inhibit skin lymphoma

by University of CopenhagenCredit: University of CopenhagenNew research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibioti
Oncology March 30,2024
Antibiotics can inhibit skin lymphoma

Antibiotics can inhibit skin lymphoma

by University of CopenhagenCredit: University of CopenhagenNew research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibioti
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com